- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis
This study is testing a new medicine, empasiprubart, for adults with a condition called dermatomyositis. It's looking at how safe the medicine is, if people can tolerate it, and if it helps improve their symptoms. Some people will get the new medicine, and others will get a dummy treatment (placebo).
For: Myositis · DermatomyositisGreece · Poland · Italy - Active not recruitingPHASE2
A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy
This study looks at the long-term effects of a medicine called ARGX-117 for adults with Multifocal Motor Neuropathy (MMN). It checks how safe and effective it is, and how the body uses and reacts to the medicine over time.
For: Multifocal Motor Neuropathy (MMN)United States · Austria · Belgium